Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$56.16 - $60.96 $401,319 - $435,620
-7,146 Reduced 25.5%
20,883 $1.26 Million
Q2 2024

Aug 20, 2024

BUY
$53.58 - $57.02 $407,208 - $433,352
7,600 Added 37.2%
28,029 $1.58 Million
Q1 2024

May 10, 2024

SELL
$42.56 - $59.82 $1.51 Million - $2.12 Million
-35,486 Reduced 63.46%
20,429 $1.15 Million
Q4 2023

Feb 02, 2024

SELL
$32.18 - $46.57 $882,536 - $1.28 Million
-27,425 Reduced 32.91%
55,915 $2.51 Million
Q3 2023

Nov 14, 2023

SELL
$44.2 - $50.2 $6,055 - $6,877
-137 Reduced 0.16%
83,340 $3.79 Million
Q2 2023

Aug 01, 2023

SELL
$31.86 - $67.26 $797,200 - $1.68 Million
-25,022 Reduced 23.06%
83,477 $3.62 Million
Q1 2023

May 05, 2023

BUY
$45.44 - $74.26 $847,183 - $1.38 Million
18,644 Added 20.75%
108,499 $7.13 Million
Q4 2022

Feb 17, 2023

BUY
$41.39 - $81.0 $918,402 - $1.8 Million
22,189 Added 32.79%
89,855 $4.04 Million
Q3 2022

Oct 26, 2022

SELL
$72.36 - $113.1 $468,024 - $731,530
-6,468 Reduced 8.72%
67,666 $4.9 Million
Q2 2022

Jul 22, 2022

SELL
$87.2 - $114.05 $621,212 - $812,492
-7,124 Reduced 8.77%
74,134 $7.95 Million
Q1 2022

Apr 22, 2022

BUY
$94.19 - $124.49 $400,119 - $528,833
4,248 Added 5.52%
81,258 $9.01 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $186,409 - $216,810
1,559 Added 2.07%
77,010 $9.86 Million
Q3 2021

Nov 05, 2021

BUY
$109.17 - $142.35 $517,793 - $675,166
4,743 Added 6.71%
75,451 $10 Million
Q2 2021

Aug 16, 2021

SELL
$100.34 - $115.69 $1,304 - $1,503
-13 Reduced 0.02%
70,708 $7.65 Million
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $287,476 - $354,764
2,832 Added 4.17%
70,721 $7.45 Million
Q4 2020

Nov 19, 2021

SELL
$85.88 - $105.36 $1.55 Million - $1.9 Million
-18,029 Reduced 20.98%
67,889 $7.07 Million
Q4 2020

Feb 18, 2021

BUY
$85.88 - $105.36 $1.45 Million - $1.78 Million
16,891 Added 24.47%
85,918 $8.94 Million
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $858,113 - $1.09 Million
-11,797 Reduced 14.6%
69,027 $5.91 Million
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $673,528 - $1.11 Million
-14,026 Reduced 14.79%
80,824 $5.93 Million
Q1 2020

May 15, 2020

BUY
$36.95 - $62.95 $116,909 - $199,173
3,164 Added 3.45%
94,850 $4.93 Million
Q4 2019

Feb 14, 2020

BUY
$47.06 - $56.64 $4.31 Million - $5.19 Million
91,686 New
91,686 $5.16 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.